Afaf El‐Malah

537 total citations
27 papers, 434 citations indexed

About

Afaf El‐Malah is a scholar working on Organic Chemistry, Pharmacology and Molecular Biology. According to data from OpenAlex, Afaf El‐Malah has authored 27 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Organic Chemistry, 11 papers in Pharmacology and 10 papers in Molecular Biology. Recurrent topics in Afaf El‐Malah's work include Synthesis and biological activity (16 papers), Synthesis and Characterization of Heterocyclic Compounds (6 papers) and Cholinesterase and Neurodegenerative Diseases (6 papers). Afaf El‐Malah is often cited by papers focused on Synthesis and biological activity (16 papers), Synthesis and Characterization of Heterocyclic Compounds (6 papers) and Cholinesterase and Neurodegenerative Diseases (6 papers). Afaf El‐Malah collaborates with scholars based in Egypt, Saudi Arabia and Australia. Afaf El‐Malah's co-authors include Asmaa E. Kassab, Eman Ahmed, Ehab M. Gedawy, Ahdab N. Khayyat, Zeinab Mahmoud, Hanan M. Refaat, Magdy M. Gineinah, Khaled O. Mohamed, Katharigatta N. Venugopala and Pran Kishore Deb and has published in prestigious journals such as Scientific Reports, Molecules and European Journal of Medicinal Chemistry.

In The Last Decade

Afaf El‐Malah

27 papers receiving 428 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Afaf El‐Malah Egypt 14 308 145 105 45 41 27 434
Omaima M. Abdelhafez Egypt 12 407 1.3× 194 1.3× 117 1.1× 42 0.9× 48 1.2× 17 548
Yasmine M. Abdel Aziz Egypt 12 296 1.0× 127 0.9× 47 0.4× 36 0.8× 62 1.5× 19 394
A. Mayweg Switzerland 13 308 1.0× 189 1.3× 117 1.1× 43 1.0× 37 0.9× 19 576
Madlen B. Labib Egypt 13 445 1.4× 100 0.7× 174 1.7× 62 1.4× 49 1.2× 17 530
Eman A. M. Beshr Egypt 18 529 1.7× 212 1.5× 92 0.9× 79 1.8× 64 1.6× 38 700
Ola I. A. Salem Egypt 14 418 1.4× 217 1.5× 62 0.6× 58 1.3× 76 1.9× 26 586
Ehab M. Gedawy Egypt 14 405 1.3× 303 2.1× 87 0.8× 43 1.0× 89 2.2× 29 640
Amal A.M. Eissa Egypt 10 309 1.0× 110 0.8× 80 0.8× 24 0.5× 40 1.0× 11 372
Jianfei Sheng China 12 175 0.6× 195 1.3× 139 1.3× 67 1.5× 37 0.9× 22 473
Dong Cao China 11 424 1.4× 285 2.0× 69 0.7× 30 0.7× 96 2.3× 20 622

Countries citing papers authored by Afaf El‐Malah

Since Specialization
Citations

This map shows the geographic impact of Afaf El‐Malah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Afaf El‐Malah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Afaf El‐Malah more than expected).

Fields of papers citing papers by Afaf El‐Malah

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Afaf El‐Malah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Afaf El‐Malah. The network helps show where Afaf El‐Malah may publish in the future.

Co-authorship network of co-authors of Afaf El‐Malah

This figure shows the co-authorship network connecting the top 25 collaborators of Afaf El‐Malah. A scholar is included among the top collaborators of Afaf El‐Malah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Afaf El‐Malah. Afaf El‐Malah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
El‐Malah, Afaf, et al.. (2024). Design, synthesis, and antiproliferative activities of novel substitutedhydrazone/triazolo-linked quinazoline derivatives. Journal of Molecular Structure. 1306. 137822–137822. 5 indexed citations
2.
Gedawy, Ehab M., et al.. (2024). Design, synthesis and in vitro anticancer activity of some new lomefloxacin derivatives. Scientific Reports. 14(1). 6175–6175. 2 indexed citations
3.
El‐Malah, Afaf, et al.. (2024). Design, synthesis, molecular docking, and molecular dynamic studies of novel quinazoline derivatives as phosphodiesterase 7 inhibitors. Frontiers in Pharmacology. 15. 1389076–1389076. 3 indexed citations
4.
Mahmoud, Zeinab, et al.. (2023). New tetracyclic systems integrated thienopyridine scaffold as an anti-dementia lead: in silico study and biological screening. Medicinal Chemistry Research. 32(3). 571–586. 3 indexed citations
5.
El‐Malah, Afaf, et al.. (2022). Selective COX-2 Inhibitors: Road from Success to Controversy and the Quest for Repurposing. Pharmaceuticals. 15(7). 827–827. 52 indexed citations
6.
El‐Malah, Afaf, et al.. (2022). In Vitro Anticancer Activity Screening of Novel Fused Thiophene Derivatives as VEGFR-2/AKT Dual Inhibitors and Apoptosis Inducers. Pharmaceuticals. 15(6). 700–700. 14 indexed citations
7.
Ahmed, Eman, et al.. (2022). Anti‐inflammatory activity of pyridazinones: A review. Archiv der Pharmazie. 355(8). e2200067–e2200067. 13 indexed citations
8.
9.
El‐Malah, Afaf, Ehab S. Taher, Andrea Angeli, et al.. (2022). Schiff bases as linker in the development of quinoline-sulfonamide hybrids as selective cancer-associated carbonic anhydrase isoforms IX/XII inhibitors: A new regioisomerism tactic. Bioorganic Chemistry. 131. 106309–106309. 17 indexed citations
10.
11.
Ahmed, Eman, et al.. (2019). Synthesis and biological evaluation of pyridazinone derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents. European Journal of Medicinal Chemistry. 171. 25–37. 51 indexed citations
12.
Ahmed, Eman, et al.. (2019). New pyridazine derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents; design, synthesis and biological evaluation. Bioorganic Chemistry. 95. 103497–103497. 38 indexed citations
13.
Gedawy, Ehab M., et al.. (2019). Synthesis and Anticancer Activity of Certain Selenophene Derivatives. Russian Journal of Organic Chemistry. 55(8). 1189–1196. 6 indexed citations
14.
Gedawy, Ehab M., et al.. (2018). Novel nalidixic acid derivatives targeting topoisomerase II enzyme; Design, synthesis, anticancer activity and effect on cell cycle profile. Bioorganic Chemistry. 83. 262–276. 24 indexed citations
15.
Gedawy, Ehab M., et al.. (2018). Synthesis of Novel Thieno[2,3-d]pyrimidine Derivatives and Evaluation of Their Cytotoxicity and EGFR Inhibitory Activity. Anti-Cancer Agents in Medicinal Chemistry. 18(5). 747–756. 10 indexed citations
16.
Mohamed, Khaled O., Yassin M. Nissan, Afaf El‐Malah, et al.. (2017). Design, synthesis and biological evaluation of some novel sulfonamide derivatives as apoptosis inducers. European Journal of Medicinal Chemistry. 135. 424–433. 36 indexed citations
17.
18.
El‐Malah, Afaf & Asmaa E. Kassab. (2016). Design, Synthesis and Biological Evaluation of New Thieno[2,3- d]pyrimidines as Anti-inflammatory Agents. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry. 14(3). 204–214. 3 indexed citations
19.
El‐Malah, Afaf, Ehab M. Gedawy, Asmaa E. Kassab, & Rania M. Abdelsalam. (2013). Novel Tacrine Analogs as Potential Cholinesterase Inhibitors in Alzheimer's Disease. Archiv der Pharmazie. 347(2). 96–103. 6 indexed citations
20.
El‐Malah, Afaf, et al.. (2010). Design, Synthesis, and Molecular‐modeling Study of Aminothienopyridine Analogues of Tacrine for Alzheimer's Disease. Archiv der Pharmazie. 343(10). 590–601. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Omaima M. Abdelhafez Breakdown of academic impact, for papers by Yasmine M. Abdel Aziz Breakdown of academic impact, for papers by A. Mayweg Breakdown of academic impact, for papers by Madlen B. Labib Breakdown of academic impact, for papers by Eman A. M. Beshr Breakdown of academic impact, for papers by Ola I. A. Salem Breakdown of academic impact, for papers by Ehab M. Gedawy Breakdown of academic impact, for papers by Amal A.M. Eissa Breakdown of academic impact, for papers by Jianfei Sheng Breakdown of academic impact, for papers by Dong Cao
Rankless by CCL
2026